Literature DB >> 28497429

Pathogenesis and FDG-PET/CT findings of Epstein-Barr virus-related lymphoid neoplasms.

Akira Toriihara1, Reiko Nakajima2, Ayako Arai3,4, Masashi Nakadate5, Koichiro Abe2, Kazunori Kubota6, Ukihide Tateishi5.   

Abstract

Epstein-Barr virus (EBV) is one of the most common viruses, infecting more than 90% of the adult population worldwide. EBV genome is detected in some lymphoid neoplasms. Not only their histopathological subtypes, but also their backgrounds and their clinical courses are variable. A number of B-cell lymphoproliferative disorders associated with the immunocompromised state are related to EBV infection. The incidences of these disorders have been increasing along with generalization of organ transplantations and use of immunosuppressive treatments. Furthermore, some EBV-positive lymphoma can also occur in immunocompetent patients. While evaluating patients with generalized lymphadenopathy of unknown cause by positron emission tomography/computed tomography with 2-deoxy-2-[18F]fluoro-D-glucose (FDG-PET/CT), the possibility of lymphoid neoplasms should be considered in some patients, and a careful review of the background and previous history of the patients is necessary. In this review article, we describe the pathogenesis of EBV-related lymphoid neoplasms and then present FDG-PET/CT images of representative diseases. In addition, we also present a review of other EBV-related diseases, such as infectious mononucleosis and nasopharyngeal carcinoma.

Entities:  

Keywords:  Epstein–Barr virus; FDG-PET/CT; Lymphoma; Lymphoproliferative diseases

Mesh:

Year:  2017        PMID: 28497429     DOI: 10.1007/s12149-017-1180-5

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  5 in total

Review 1.  Epstein-Barr virus and its association with disease - a review of relevance to general practice.

Authors:  Anders Fugl; Christen Lykkegaard Andersen
Journal:  BMC Fam Pract       Date:  2019-05-14       Impact factor: 2.497

Review 2.  Chronic Active Epstein-Barr Virus Infection: The Elucidation of the Pathophysiology and the Development of Therapeutic Methods.

Authors:  Ayako Arai
Journal:  Microorganisms       Date:  2021-01-15

3.  The Role of Pre-therapeutic 18F-FDG PET/CT in Pediatric Hemophagocytic Lymphohistiocytosis With Epstein-Barr Virus Infection.

Authors:  Xia Lu; Ang Wei; Xu Yang; Jun Liu; Siqi Li; Ying Kan; Wei Wang; Tianyou Wang; Rui Zhang; Jigang Yang
Journal:  Front Med (Lausanne)       Date:  2022-01-21

4.  Case Report: Chronic Active Epstein-Barr Virus Infection With Subcutaneous Nodules and Systemic Damage.

Authors:  Huating Luo; Zhe Yuan; Bo Qin
Journal:  Front Med (Lausanne)       Date:  2022-03-31

Review 5.  Chronic active Epstein-Barr virus infection of T-cell type, systemic form in an African migrant: case report and review of the literature on diagnostics standards and therapeutic options.

Authors:  Maxi Wass; Marcus Bauer; Roald Pfannes; Kerstin Lorenz; Andreas Odparlik; Lutz P Müller; Claudia Wickenhauser
Journal:  BMC Cancer       Date:  2018-10-03       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.